Stereotaxis with new tech development
Shares of cardiology instruments systems manufacturer Stereotaxis, Inc. (Nasdaq: STXS) are sagging despite news the St. Louis, Mo.-based company has developed an innovative new interface.
“Odyssey” is a new product that consolidates multiple information sources and screens within an electrophysiology interventional lab into a single visual display, Stereotaxis said before the opening bell.
“Odyssey” is a new product that consolidates multiple information sources and screens within an electrophysiology interventional lab into a single visual display, Stereotaxis said before the opening bell.
For access to the full article, you must be a registered member - it's FREE.
Already a member? Please log in below
Not Registered?
Register today and enjoy all that SmallCapInvestor.com has to offer, including:
- Daily small cap stock profiles.
- Intra-day coverage of Russell 2000 companies.
- Research and insights from our analysts.
- Special reports.
